In addition to lowering the number of monthly migraine days, galcanezumab may also reduce the need for acute medication in patients with migraine. A new post-hoc analysis presented at the American Headache...
Previous studies have suggested that riboflavin supplementation could help prevent migraine in adults. Despite being widely available via the food supply, little information is available on the average...
Research has suggested that telemedicine can help increase access to care in a variety of locations and circumstances. In a new study, researchers aimed to assess its efficacy as an alternative to in-office...
In a phase 2b/3 study, a new orally administered CGRP receptor antagonist showed positive results in preventing migraines. Results were presented at the American Headache Society’s 61st Annual Scientific...
Encouraging findings presented at the American Headache Society’s 61st Annual Scientific Meeting suggest that yoga could play a key role in a treatment regimen for migraine.
Research led by Richard B. Lipton, MD, from the Albert Einstein College of Medicine, highlights the incidence of migraine in the United States. He presented his findings at the American Headache Society’s...
A study presented at the American Headache Society’s 61st Annual Scientific Sessions investigated the correlation between migraine and cardiovascular disease outcomes among older women participating in the...
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Despite recommendations against their use, opioids are still commonly prescribed for patients with migraine. A new review presented at the American Headache Society’s 61st Annual Scientific Meeting assessed...
